Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heterogeneity in acute myeloblastic leukemia.

E A McCulloch1, C A Kelleher, J Miyauchi

  • 1Division of Biological Research, Ontario Cancer Institute, Toronto, Canada.

Leukemia
|December 1, 1988
PubMed
Summary

Acute myeloblastic leukemia (AML) blasts show significant heterogeneity. Targeting self-renewal divisions with drugs like ara-C may improve preclinical testing for AML treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stable expression of Epstein-Barr virus BZLF-1-encoded ZEBRA protein activates p53-dependent transcription in human Jurkat T-lymphoblastoid cells.

Blood·2000
Same author

Inactivation of NF-kappaB by EBV BZLF-1-encoded ZEBRA protein in human T cells.

Journal of immunology (Baltimore, Md. : 1950)·1999
Same author

Definition and adjustment of Cesarean section rates and assessments of hospital performance.

International journal for quality in health care : journal of the International Society for Quality in Health Care·1999
Same author

Dissociation of EBV genome replication and host cell proliferation in anti-IgG-stimulated Akata cells.

Clinical immunology and immunopathology·1996
Same author

Nerve growth factor signal transduction in human B lymphocytes is mediated by gp140trk.

European journal of immunology·1996
Same author

Epstein-Barr virus infection of T cells: implications for altered T-lymphocyte activation, repertoire development and autoimmunity.

Immunological reviews·1996

Area of Science:

  • Hematology
  • Cancer Biology
  • Cellular Biology

Background:

  • Acute myeloblastic leukemia (AML) is characterized by malignant blast populations dominating hematopoiesis.
  • AML blasts exhibit marked heterogeneity, leading to patient-to-patient variations in biological properties and treatment response.
  • Intraclonal variation arises during clonal expansion, with blast stem cells balancing self-renewal and differentiation.

Purpose of the Study:

  • To investigate the balance between self-renewal and differentiation in AML blast populations.
  • To explore the impact of growth factors and drugs on AML blast stem cell behavior.
  • To propose a preclinical testing strategy for AML therapies focusing on self-renewal effects.

Main Methods:

  • Utilized clonogenic and suspension assays to monitor self-renewal and differentiation activities of AML blast stem cells in culture.

Related Experiment Videos

  • Exposed blast populations to various growth factors to assess alterations in the renewal-differentiation balance.
  • Evaluated the toxicity of drugs, specifically ara-C, on self-renewing divisions versus general cell-cycle events.

    • Main Results:

    • The balance between blast stem cell self-renewal and differentiation can be modulated by growth factors in culture.
    • The drug ara-C demonstrated higher toxicity towards self-renewing divisions compared to general cell-cycle events.
    • These findings highlight differential drug sensitivity based on cell division type.

    Conclusions:

    • Self-renewal is a critical target for therapeutic intervention in AML.
    • Preclinical testing should incorporate assessments of drug and growth factor effects on blast stem cell self-renewal.
    • Modulating the self-renewal capacity of AML blasts holds therapeutic potential.